thorax.bmj

Optimal timing, duration and sequencing of therapy for progressive pulmonary fibrosis: the urgent need to move beyond the ‘wait-to-fail’ paradigm

Progressive pulmonary fibrosis (PPF) is not merely a diagnostic umbrella; it is a continuous, irreversible cascade of fibroproliferation that carries a mortality rate rivalling many aggressive ...
thorax.bmj

Corticosteroids in COPD carry the danger of fatal aspergillosis

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
thorax.bmj

The role of facemask spirometry in motor neuron disease

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
thorax.bmj

Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
thorax.bmj

The clinical spectrum of pulmonary aspergillosis

The National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Correspondence to Dr Chris Kosmidis, ...
thorax.bmj

British Thoracic Society guideline for respiratory management of children with neuromuscular weakness

1 Department of Paediatrics, Oxford University Hospitals NHS Trust, Oxford, UK 2 Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK ...
thorax.bmj

A systematic review of the use of opioids in the management of dyspnoea

1 Department of Palliative Medicine, The North London Hospice and Barnet and Chase Farm Hospitals NHS Trust, London N12 8TF, UK 2 Department of Palliative Medicine, Bristol Haematology and Oncology ...
thorax.bmj

Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We previously published a genome-wide meta-analysis of IPF risk across three studies with independent ...
thorax.bmj

Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study

9 Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany Background The impact of pulmonary rehabilitation (PR) on survival in patients ...
thorax.bmj

Minimum clinically important improvement for the incremental shuttle walking test

Pulmonary Rehabilitation Research Group, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK Background: The ...
thorax.bmj

The COPD control panel: towards personalised medicine in COPD

Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced ...
thorax.bmj

Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study

Rationale Using latent class analysis (LCA), two subphenotypes of acute respiratory distress syndrome (ARDS) have consistently been identified in five randomised controlled trials (RCTs), with ...